| Literature DB >> 22702476 |
Antonius Schneider1, Nadine Großmann, Klaus Linde.
Abstract
BACKGROUND: Governmental funding support is seen as a prerequisite for the growth of research in general practice. Several funding programs in the amount of € 13.2 Mio were introduced in Germany from 2002 to February 2012. We aim to provide an overview of publications reporting original data and systematic reviews from German academic family medicine published between 2000 and 2010.Entities:
Mesh:
Year: 2012 PMID: 22702476 PMCID: PMC3489844 DOI: 10.1186/1471-2296-13-58
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Figure 1Overview of included studies (classification according to [2]).
Figure 2Flow chart.
Figure 3Number of research publications per year.
Cross-tabulation of study subject and study type
| Health services research (n = 314) | 174 (55.5%) | 35 (11.1%) | 52 (16.6%) | 39 (12.4%) | 8 (2.5%) | | | 6 (1.9%) |
| Clinical research (n = 216) | 67 (31.0%) | 43 (19.9%) | 1 (0.5%) | 26 (12.0%) | 46 (21.3%) | | 24 (11.1%) | 9 (4.2%) |
| Exploring patients’ views (n = 59) | 42 (71.2%) | 3 (5.1%) | 13 (22.0%) | | 1 (1.9%) | | | |
| Methodology (n = 57) | 16 (28.1%) | 2 (3.5%) | 1 (1.8%) | 2 (3.5%) | 2 (3.5%) | 34 (59.6%) | | |
| Medical education (n = 53) | 43 (81.1%) | 7 (13.2%) | 1 (1.9%) | | | 1 (1.9%) | | 1 (1.9%) |
| Various (n = 95) | 47 (49.5%) | 9 (9.5%) | 10 (10.5%) | 5551 | 15 (15.8%) | 1 (1.9%) | 8 (8.4%) |
Diagnostic groups of the published studies, according to ICPC-2 (n = 393 with a specific disease focus; few studies with more than one disease)
| - Psychiatry | 90 (22,9%) |
|---|---|
| - Circulatory | 85 (21,6%) |
| - Muskuloskeletal | 64 (16,3%) |
| - Respiratory | 53 (13,5%) |
| - Metabolic, endocrinology | 49 (12,5%) |
| - Digestive | 20 (5,1%) |
| - Neurology | 16 (4,1%) |
| - Urology | 15 (3,8%) |
| - General | 8 (2,0%) |
| - Skin | 8 (2,0%) |
| - Male genital | 4 (1,0%) |
| - Pregnancy | 2 (0,5%) |
| - Female genital | 2 (0,5%) |
| - Ear | 1 (0,3%) |
Development of the publication output
| Number of publications | 107 | 273 | 414 | | 794 |
| Number of groups with publication | 19 | 25 | 25 | | 28 |
| Type of study | |||||
| - cross-sectional | 52.3% | 56.4% | 43.2% | .003 | 49.0% |
| - cohort/case–control | 13.1% | 8.8% | 14.7% | .07 | 12.5% |
| - qualitative | 10.3% | 8.1% | 10.9% | .47 | 9.8% |
| - intervention | 10.3% | 10.3% | 8.0% | .53 | 9.1% |
| - systematic reviews | 9.3% | 8.1% | 9.7% | .77 | 9.1% |
| - instrumental/other | 3.7% | 6.2% | 9.4% | .08 | 7.6% |
| - diagnostic studies | 0.9% | 2.2% | 4.1% | .14 | 3.0% |
| Subject of study | |||||
| - health services research | 43.0% | 39.9% | 38.4% | .68 | 39.5% |
| - clinical research | 22.4% | 26.0% | 29.2% | .32 | 27.2% |
| - exploring patients’ views | 10.3% | 8.1% | 6.3% | .33 | 7.4% |
| - methodology | 5.6% | 4.8% | 9.2% | .07 | 7.2% |
| - medical education | 2.8% | 10.6% | 5.1% | .004 | 6.7% |
| - various | 15.9% | 10.6% | 11.8% | .36 | 12.0% |
| Authorship characteristics | |||||
| - total number of authors | 4 (1-45) | 5 (1-27) | 5 (1-86) | < .001 | 5 (1-86) |
| - number of authors GP division | 2 (1-7) | 3 (1-11) | 3 (1-9) | .001 | 3 (1-11) |
| - proportion of GP authors | 0.75 (0.02-1) | 0.67 (0.04-1) | 0.67 (0.01-1) | .27 | 0.67 (0.01-1) |
| - first author from GP division | 70.1% | 74.0% | 70.3% | .054 | 71.5% |
| - last author from GP division | 60.7% | 62.3% | 67.6% | .22 | 64.9% |
| - statistician as co-author | 7.5% | 11.7% | 19.1% | .002 | 15.0% |
| - co-author from other department | 36.8% | 43.6% | 46.9% | .17 | 44.4% |
| - international co-author | 11.2% | 13.9% | 23.4% | .001 | 18.5% |
| Published in English | 24.3% | 45.5% | 60.6% | < .001 | 50.5% |
| Impact factor | |||||
| - median (range) | 0 (0-10.0) | 0.7 (0-16.7) | 1.2 (0-36.4) | < .001 | 0.7 (0-36.4) |
| - without impact factor | 59.8% | 43.6% | 31.9% | < .001 | 39.7% |
| - 0.001 to 2 | 35.5% | 48.7% | 58.0% | | 51.7% |
| - 2.001 to 4 | 9.3% | 13.6% | 21.5% | | 18.1% |
| - 4.001 to 10 | 3.7% | 6.2% | 8.2% | | 6.9% |
| - > 10 | 0.9% | 1.5% | 1.9% | 1.6% | |